Macquarie Downgrades Quest Diagnostics (DGX) to Neutral
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $244.39 +1.28%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Macquarie downgraded Quest Diagnostics (NYSE: DGX) from Outperform to Neutral with a price target cut from $62 to $52.
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $57.28 yesterday.
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $57.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WHOOP Makes Advanced Labs Available Without a Wearable Membership
- UBS Downgrades Alkane Resources (ALK:AU) to Neutral
- Canaccord Downgrades Northern Star Resources (NST:AU) (NESRF) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
